Introduction: In this study we explicated early results of patients (the patients in whom levosimendan was used) who underwent coronary artery bypass graft surgery with ejection fraction 35% or less. We compared this ...Introduction: In this study we explicated early results of patients (the patients in whom levosimendan was used) who underwent coronary artery bypass graft surgery with ejection fraction 35% or less. We compared this group with the patients in whom levo-simendan was not used. Material and Methods: 97 patients who have 35% ejection fraction or less taken to isolated coronary artery bypass surgery between January 2009 and December 2011 in our clinic are chosen for this study retrospectively. We compared the patients in whom levosimendan was used with the patients in whom levosimendan was not used. Levo- simendan (Simdax, Abbott) has been used according to surgeon’s decision in patients. Results: The mean age of group 1 was 62.3 ± 7.6, and the mean age of group 2 was 59.3 ± 10.5 (p > 0.05). It was detected that the average ejection fraction was less in group 1 (p 0.05). It was found that need for blood transfusion were less in group 1 than group 2 (p 0.05). Conclusion: We consider levosimendan reduces need for blood transfusion in coronary artery bypass graft surgery. This results may change with increasing number of patients so we consider that multicenter larger study is needed.展开更多
Introduction: In this study we examined the early results of coronary artery bypass surgery in our female patients and compared them with those of our male patients. Material and Methods: One thousand and ninety four ...Introduction: In this study we examined the early results of coronary artery bypass surgery in our female patients and compared them with those of our male patients. Material and Methods: One thousand and ninety four patients who underwent coronary artery bypass surgery between January 2009 and December 2011 inour clinic were included into this study. Three hundred and thirteen female patients (group 1) were compared to 781 male patients (group 2). Results: The mean age of group 1 was 61.4 ± 9.6, and the mean age of group 2 was 58.1 ± 9.6 (p < 0.001). The ratio of diabetes mellitus and hypertension in group 1 was higher than that of group 2 (p < 0.001). There were no significant difference between two groups when compared regarding the need for inotropics after weaning from cardiopulmonary bypass, cross clamp and total cardiopulmonary bypass periods (p > 0.05). It was found that the amount of drainage was higher in group 1 than group 2 (p < 0.001). There was no significant difference between two groups when compared in terms of mortality, re-operation (because of bleeding), postoperative atrial fibrillation, need for intraaortic balloon pump, usage of levosimendan, cerebrovascular accident, chronic renal failure, discharging intervals and period in intensive care unit. It was found that sternal wound infection was higher in group 1 than group 2 (p < 0.05). Conclusion: We consider that female gender does not put an additional risk to increase mortality and morbidity in coronary artery bypass surgery.展开更多
文摘Introduction: In this study we explicated early results of patients (the patients in whom levosimendan was used) who underwent coronary artery bypass graft surgery with ejection fraction 35% or less. We compared this group with the patients in whom levo-simendan was not used. Material and Methods: 97 patients who have 35% ejection fraction or less taken to isolated coronary artery bypass surgery between January 2009 and December 2011 in our clinic are chosen for this study retrospectively. We compared the patients in whom levosimendan was used with the patients in whom levosimendan was not used. Levo- simendan (Simdax, Abbott) has been used according to surgeon’s decision in patients. Results: The mean age of group 1 was 62.3 ± 7.6, and the mean age of group 2 was 59.3 ± 10.5 (p > 0.05). It was detected that the average ejection fraction was less in group 1 (p 0.05). It was found that need for blood transfusion were less in group 1 than group 2 (p 0.05). Conclusion: We consider levosimendan reduces need for blood transfusion in coronary artery bypass graft surgery. This results may change with increasing number of patients so we consider that multicenter larger study is needed.
文摘Introduction: In this study we examined the early results of coronary artery bypass surgery in our female patients and compared them with those of our male patients. Material and Methods: One thousand and ninety four patients who underwent coronary artery bypass surgery between January 2009 and December 2011 inour clinic were included into this study. Three hundred and thirteen female patients (group 1) were compared to 781 male patients (group 2). Results: The mean age of group 1 was 61.4 ± 9.6, and the mean age of group 2 was 58.1 ± 9.6 (p < 0.001). The ratio of diabetes mellitus and hypertension in group 1 was higher than that of group 2 (p < 0.001). There were no significant difference between two groups when compared regarding the need for inotropics after weaning from cardiopulmonary bypass, cross clamp and total cardiopulmonary bypass periods (p > 0.05). It was found that the amount of drainage was higher in group 1 than group 2 (p < 0.001). There was no significant difference between two groups when compared in terms of mortality, re-operation (because of bleeding), postoperative atrial fibrillation, need for intraaortic balloon pump, usage of levosimendan, cerebrovascular accident, chronic renal failure, discharging intervals and period in intensive care unit. It was found that sternal wound infection was higher in group 1 than group 2 (p < 0.05). Conclusion: We consider that female gender does not put an additional risk to increase mortality and morbidity in coronary artery bypass surgery.
